Omicron BA.4/5-Delta COVID-19 Vaccine
N/A
Report date: 2023/10/10 20:05:08
Base Information
Drug NameOmicron BA.4/5-Delta COVID-19 Vaccine
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnhui Zhifei Longcom Biopharmaceutical Co LtdHunan Provincial Center for Disease Control and Prevention
China Registration ClassN/A
Develop Information
Active CompaniesAnhui Zhifei Longcom Biopharmaceutical Co LtdHunan Provincial Center for Disease Control and Prevention
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A